Phase II trial of interferon-B in patients with metastatic cutaneous melanoma and metastatic ocular melanoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon beta (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 02 Oct 2015 Biomarkers information updated
- 16 Dec 2008 Planned number of patients changed from 28 to 56 as reported by ClinicalTrials.gov.
- 17 Jul 2007 Status changed from in progress to completed.